NasdaqCM - Delayed Quote USD

Exact Sciences Corporation (EXAS)

58.85 +0.06 (+0.10%)
At close: April 26 at 4:00 PM EDT
58.95 +0.10 (+0.17%)
After hours: April 26 at 6:48 PM EDT

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Kevin T. Conroy Chairman of The Board & CEO 3.14M -- 1966
Mr. Jeffrey T. Elliott CFA EVP & CFO 1.13M -- 1978
Mr. Jake Orville MBA Executive VP & General Manager of Pipeline 1.04M -- 1974
Mr. Everett V. Cunningham Chief Commercial Officer & Executive VP 1.6M -- 1966
Mr. Brian Baranick Executive VP & General Manager of Precision Oncology 942.89k -- 1978
Dr. Jorge A. Garces Ph.D. Chief Science Officer -- -- 1972
Mr. Nassar Nizami Chief Information Officer -- -- --
Ms. Megan Jones Associate Manager of Investor Relations -- -- --
Mr. Tim Caprez Chief Compliance Counsel & VP -- -- --
Mr. James Herriott Senior VP, General Counsel & Secretary -- -- 1980

Exact Sciences Corporation

5505 Endeavor Lane
Madison, WI 53719
United States
608 284 5700 https://www.exactsciences.com
Sector: 
Healthcare
Full Time Employees: 
6,500

Description

Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX Breast Recurrence Score Test; Oncotype DX Breast DCIS Score Test; Oncotype DX Colon Recurrence Score Test; OncoExTra Test for tumor profiling for patients with advanced, metastatic, refractory, relapsed, or recurrent cancer; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research, and Johns Hopkins University. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.

Corporate Governance

Exact Sciences Corporation’s ISS Governance QualityScore as of April 1, 2024 is 3. The pillar scores are Audit: 1; Board: 5; Shareholder Rights: 3; Compensation: 7.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

Upcoming Events

May 08, 2024
Exact Sciences Corporation Earnings Call

Related Tickers

GH Guardant Health, Inc.
17.35
+1.11%
 
ILMN Illumina, Inc.
122.28
+1.02%
 
TWST Twist Bioscience Corporation
31.54
+1.48%
 
NTRA Natera, Inc.
91.66
+0.42%
 
DHR Danaher Corporation
246.58
+0.32%
 
TMO Thermo Fisher Scientific Inc.
573.60
+0.33%
 
LH Laboratory Corporation of America Holdings
198.40
+0.03%
 
DGX Quest Diagnostics Incorporated
134.26
-0.86%
 
MEDP Medpace Holdings, Inc.
395.93
+1.58%
 
VCYT Veracyte, Inc.
19.31
-0.87%